Global Meningococcal Initiative

A worldwide expert group raising awareness and helping prevent invasive meningococcal disease

The Global Meningococcal Initiative (GMI) and Meningitis Research Foundation (MRF) are in partnership to promote and share world class research into best practice about prevention, diagnosis and treatment of meningococcal disease around the world.

Meningococcal bacteria are the main cause of life-threatening meningitis and septicaemia throughout the world.

A new worldwide expert group to raise awareness and help prevent invasive meningococcal disease

"This partnership can be instrumental in helping to share and build a better understanding of the global picture of this dreadful disease. I look forward to seeing researchers and health professionals around the world accessing and using the information to help them in their work." - Professor Ray Borrow, GMI Steering Group Member.

GMI's international meetings, publications, posters and recommendations

"MRF is delighted to partner with GMI on this important initiative. We want to ensure that GMI's body of research reaches the communities and people who can use and apply the findings to directly help patients and their families as soon as possible." - Vinny Smith, MRF Chief Executive, GMI Steering Group Member.

A global vision for meningitis by 2030 and an action plan to get there.
Key data and meningitis estimates
Meningitis affects 5 million people globally every year
Our Director of Communications explores the risk of climate change in relation to meningitis.
Give researchers the clues to help defeat meningitis
Give researchers the clues to help defeat meningitis
£160/€190/$214 decodes the genetic information in a sample of meningococcal bacteria. This information helps us to track new forms of meningitis and campaign to introduce new vaccines.